Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 5/20 | 0.36 |
| ▸ | PPARG | P37231 | 5/20 | 0.36 |
| ▸ | RARG | P13631 | 4/20 | 0.36 |
| ▸ | THRB | P10828 | 3/20 | 0.34 |
| ▸ | RARA | P10276 | 1/20 | 0.33 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | RXRG | P48443 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29842995 | 1.00 | RXRA (0.36) | RXRAPPARGRARGTHRBRARA | |
| SCHEMBL2612511 | 0.91 | RXRA (0.36) | RXRAPPARGRARGTHRBRARA | |
| SCHEMBL30123296 | 0.88 | RXRA (0.40) | RXRAPPARGRARGTHRBRARA | |
| SCHEMBL9448615 | 0.84 | RXRA (0.36) | RXRAPPARGRARGRARARARB | |
| SCHEMBL27242779 | 0.83 | RXRA (0.38) | RXRAPPARGRARGTHRBRARA | |
| SCHEMBL2706073 | 0.83 | HSPA5 (0.40) | RXRAPPARGRARGSMN1; SMN2 | |
| SCHEMBL12856180 | 0.82 | RXRA (0.34) | RXRAPPARGRARGRARARARB | |
| SCHEMBL9657298 | 0.82 | GAA (0.38) | THRBALDH1A1MAPK1NPSR1 | |
| SCHEMBL7191459 | 0.81 | RXRA (0.36) | RXRAPPARGRARGTHRBRARA | |
| SCHEMBL17471442 | 0.81 | RXRA (0.41) | RXRAPPARGRARGTHRBRARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1394204-A1 | BLOCK COPOLYMER COMPOSITION | Asahi Kasei Kabushiki Kaisha (JP) | 2004-03-03 | — | — | EP | claimed |
| EP-0500323-A2 | Production of bisphenol monoester | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-08-26 | — | — | EP | claimed |
| US-20250236727-A1 | THERMOPLASTIC RESIN COMPOSITION, METHOD OF PREPARING THE SAME, AND MOLDED ARTICLE INCLUDING THE SAME | LG CHEM, LTD. (KR) | 2025-07-24 | — | — | US | disclosed |
| US-20250197621-A1 | THERMOPLASTIC RESIN COMPOSITION | MITSUI CHEMICALS, INC. (JP) | 2025-06-19 | — | — | US | disclosed |
| US-20250051564-A1 | RESIN COMPOSITION, MOLDED ARTICLE, AND METHOD FOR PRODUCING RESIN COMPOSITION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-02-13 | — | — | US | disclosed |
| US-12060453-B2 | Polyester carbonate resin, and molded body which is obtained by molding resin composition containing resin | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-08-13 | — | — | US | disclosed |
| US-20240254282-A1 | THERMOPLASTIC RESIN COMPOSITION, COMMUNICATION DEVICE MEMBER, AND MICROWAVE AND/OR MILLIMETER WAVE COMMUNICATION DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-08-01 | — | — | US | disclosed |
| WO-2024135577-A1 | STABLE DISPERSION COMPOSITION COMPRISING RETINOID | L'OREAL (FR) | 2024-06-27 | — | — | WO | disclosed |
| WO-2023249852-A1 | IONOMER RESIN COMPOSITION | TREANOR, Richard (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023249122-A1 | STABILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | L'OREAL (FR) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023249853-A1 | IONOMER RESIN COMPOSITION | KURARAY AMERICA, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2011014210-A2 | LIQUID PHOSPHITE COMPOSITIONS HAVING DIFFERENT ALKYL GROUPS | CHEMTURA CORPORATION (US) | 2011-02-03 | — | — | WO | disclosed |
| WO-2011014477-A1 | LIQUID ALKYLATED TRISARYL PHOSPHITE COMPOSITIONS HAVING TWO ALKYL GROUPS WITH DIFFERENT CARBON NUMBER | CHEMTURA CORPORATION (US) | 2011-02-03 | — | — | WO | disclosed |
| US-7781534-B2 | Process for producing vinyl polymer, vinyl polymer, and curable composition | KANEKA CORPORATION (JP) | 2010-08-24 | — | — | US | disclosed |
| US-20090143517-A1 | Bisphenol Monoester compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20080160621-A1 | Process for producing vinyl polymer, vinyl polymer, and curable composition | KANEKA CORPORATION (JP) | 2008-07-03 | — | — | US | disclosed |
| WO-2006047665-A1 | COMPOSITION COMPRISING A MONOVINYLARENE-CONJUGATED DIENE COPOLYMER AND AN ACRYLATE TERPOLYMER AND SHRINK FILMS MADE THEREOF | CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) | 2006-05-04 | — | — | WO | disclosed |
| EP-1033243-B1 | Aromatic polycarbonate resin coextruded article | ASAHI DENKA KOGYO KK (JP) | 2002-06-12 | — | — | EP | disclosed |
| US-6333114-B1 | WEATHERABILITY AND IMPROVED COLORING RESISTANCE; FOR PRODUCING MOLDED ARTICLES SUCH AS FOOD PACKAGING CONTAINERS, INTERIOR AND EXTERIOR AUTOMOTIVE TRIM PARTS, AND PRECISION MACHINES, FILMS | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 2001-12-25 | — | — | US | disclosed |
| EP-1033243-A1 | Aromatic polycarbonate resin coextruded article | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 2000-09-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143517-A1 | Bisphenol Monoester compound | CYP19A1, ESR1, ESRRA | RXRA 104/4885PPARG 121/4885RARG 233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.